Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2747 results

Clinical Trials / Oct 16, 2025

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trials / Jun 29, 2025

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
Clinical Trials / Dec 22, 2025

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Novartis quarterly financial results
Event calendar
Home
Novartis annual results
Event / Oct 28, 2025

Novartis 2025 Financial Results

Novartis announces the company’s fourth quarter and 2025 full year financial results.
Press release / Nov 19, 2025

Novartis announces plans to build flagship manufacturing hub in North Carolina

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic…
Event / Feb 04, 2026

Novartis Financial Results - Q3 2026

Novartis announces the company’s financial results for the third quarter of 2026.

‹ Previous page
1
…
14
15
16
17
18
19
20
…
275
› Next page